127 related articles for article (PubMed ID: 10415893)
1. Imidazoline binding domains on MAO-B. Localization and accessibility.
Raddatz R; Savic SL; Lanier SM
Ann N Y Acad Sci; 1999 Jun; 881():26-31. PubMed ID: 10415893
[TBL] [Abstract][Full Text] [Related]
2. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B.
Raddatz R; Lanier SM
Neurochem Int; 1997 Jan; 30(1):109-17. PubMed ID: 9116581
[TBL] [Abstract][Full Text] [Related]
3. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B.
Raddatz R; Parini A; Lanier SM
J Biol Chem; 1995 Nov; 270(46):27961-8. PubMed ID: 7499273
[TBL] [Abstract][Full Text] [Related]
4. The elusive family of imidazoline binding sites.
Parini A; Moudanos CG; Pizzinat N; Lanier SM
Trends Pharmacol Sci; 1996 Jan; 17(1):13-6. PubMed ID: 8789353
[TBL] [Abstract][Full Text] [Related]
5. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit.
Lanier B; Raddatz R; Bakthavachalam V; Coupry I; Neumeyer JL; Lanier SM
Mol Pharmacol; 1995 Oct; 48(4):703-10. PubMed ID: 7476897
[TBL] [Abstract][Full Text] [Related]
6. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL
J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560
[TBL] [Abstract][Full Text] [Related]
7. Localization of the imidazoline binding domain on monoamine oxidase B.
Raddatz R; Parini A; Lanier SM
Mol Pharmacol; 1997 Oct; 52(4):549-53. PubMed ID: 9380016
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
9. Association between I(2) binding sites and monoamine oxidase-B activity in platelets.
Zhu H; Piletz JE
Ann N Y Acad Sci; 2003 Dec; 1009():347-52. PubMed ID: 15028609
[TBL] [Abstract][Full Text] [Related]
10. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.
McDonald GR; Olivieri A; Ramsay RR; Holt A
Pharmacol Res; 2010 Dec; 62(6):475-88. PubMed ID: 20832472
[TBL] [Abstract][Full Text] [Related]
11. Relationship between I2 imidazoline binding sites and monoamine oxidase B in liver.
Remaury A; Ordener C; Shih J; Parini A
Ann N Y Acad Sci; 1999 Jun; 881():32-4. PubMed ID: 10415894
[TBL] [Abstract][Full Text] [Related]
12. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
[TBL] [Abstract][Full Text] [Related]
14. Relationship between imidazoline(2) sites and monoamine oxidase.
Paterson LM; Tyacke RJ; Nutt DJ; Hudson AL
Ann N Y Acad Sci; 2003 Dec; 1009():353-6. PubMed ID: 15028610
[TBL] [Abstract][Full Text] [Related]
15. Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme.
Raddatz R; Savic SL; Bakthavachalam V; Lesnick J; Jasper JR; McGrath CR; Parini A; Lanier SM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1135-45. PubMed ID: 10688633
[TBL] [Abstract][Full Text] [Related]
16. Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.
Soto J; Ulibarri I; Jauregui JV; Ballesteros J; Meana JJ
J Psychiatr Res; 1999; 33(3):251-7. PubMed ID: 10367991
[TBL] [Abstract][Full Text] [Related]
17. Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: regulation by I2 imidazoline ligands in intact cells.
Gargalidis-Moudanos C; Remaury A; Pizzinat N; Parini A
Mol Pharmacol; 1997 Apr; 51(4):637-43. PubMed ID: 9106629
[TBL] [Abstract][Full Text] [Related]
18. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
King PR; Gundlach AL; Louis WJ
Ann N Y Acad Sci; 1999 Jun; 881():161-70. PubMed ID: 10415911
[TBL] [Abstract][Full Text] [Related]
19. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
Holt A; Todd KG; Baker GB
Ann N Y Acad Sci; 2003 Dec; 1009():309-22. PubMed ID: 15028605
[TBL] [Abstract][Full Text] [Related]
20. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
